Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes endoplasmic reticular disruption and cellular senescence by Pantazi, Asimina et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes
endoplasmic reticular disruption and cellular senescence
Citation for published version:
Pantazi, A, Quintanilla, A, Hari, P, Tarrats, N, Parasyraki, E, Dix, F, Patel, J, Chandra, T, Acosta, J & Finch,
A 2019, 'Inhibition of the 60S ribosome biogenesis GTPase LSG1 causes endoplasmic reticular disruption
and cellular senescence' Aging Cell. DOI: 10.1111/acel.12981
Digital Object Identifier (DOI):
10.1111/acel.12981
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Aging Cell
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 21. Jun. 2019
Aging Cell. 2019;00:e12981.	 	 	 | 	1 of 18
https://doi.org/10.1111/acel.12981
wileyonlinelibrary.com/journal/acel
1  | INTRODUC TION
Mammalian ribosomes are nucleoprotein complexes comprised of 
a large (60S) subunit and a small (40S) subunit that carry out the 
fundamental process of translation. The mature ribosome contains 
four ribosomal RNAs (rRNAs) and almost 80 proteins, and the com‐
plex process of ribosome biogenesis involves over 200 trans‐acting 
factors (reviewed in Kressler, Hurt, and Baßler (2017)). Transcription 
of rRNA precursors from tandem repeats of ribosomal DNA (rDNA) 
initiates ribosome biogenesis, and a complex sequence of events 
including sequential splicing and recruitment of rRNA‐associated 
proteins ensues. Mutations in genes that encode core ribosomal pro‐
teins or factors involved in ribosome biogenesis give rise to diseases 
that are collectively termed ribosomopathies. Examples of these 
inherited disorders include Treacher Collins syndrome, Diamond–
Blackfan anaemia and Shwachman–Diamond syndrome (reviewed 
in Danilova and Gazda (2015)). The acquired myelodysplastic syn‐
drome 5q‐, characterized by a deletion of a region of chromosome 
5q, is also considered a ribosomopathy due to the presence of the 
RPS14 gene in the deleted region and the phenotypic recapitulation 
of much of the disease phenotype upon deletion of RPS14 alone 
(Barlow et al., 2010; Ebert et al., 2008). Given the requirement for 
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Abstract
Cellular senescence is triggered by diverse stimuli and is characterized by long‐term 
growth arrest and secretion of cytokines and chemokines (termed the SASP—senes‐
cence‐associated secretory phenotype). Senescence can be organismally beneficial 
as it can prevent the propagation of damaged or mutated clones and stimulate their 
clearance by immune cells. However, it has recently become clear that senescence 
also contributes to the pathophysiology of aging through the accumulation of dam‐
aged cells within tissues. Here, we describe that inhibition of the reaction catalysed 
by LSG1, a GTPase involved in the biogenesis of the 60S ribosomal subunit, leads to 
a robust induction of cellular senescence. Perhaps surprisingly, this was not due to 
ribosome depletion or translational insufficiency, but rather through perturbation of 
endoplasmic reticulum homeostasis and a dramatic upregulation of the cholesterol 
biosynthesis pathway. The underlying transcriptomic signature is shared with several 
other forms of senescence, and the cholesterol biosynthesis genes contribute to the 
cell cycle arrest in oncogene‐induced senescence. Furthermore, targeting of LSG1 
resulted in amplification of the cholesterol/ER signature and restoration of a robust 
cellular senescence response in transformed cells, suggesting potential therapeutic 
uses of LSG1 inhibition.
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ribosome biogenesis in cellular growth and proliferation, the caus‐
ative mutation in these diseases is clearly detrimental to the cell. 
However, the pathology that arises in these ribosomopathies is, in 
many cases, caused by activation of the p53 pathway in response 
to the primary lesions (Barkic et al., 2009; Barlow et al., 2010; Jones 
et al., 2008). The exact nature of the stresses that activate the p53 
pathway in the ribosomopathies remains undefined.
Regulation of ribosome biogenesis occurs primarily at the level 
of the transcriptional complexes that are recruited to the rDNA. 
The majority of rRNA is produced by RNA polymerase I‐mediated 
transcription, and this activity requires recruitment of TIF‐1A (tran‐
scription initiation factor 1A), UBF (upstream binding factor) and SL1 
(selectivity factor 1) to rDNA promoter regions. All of these factors 
are regulated by phosphorylation, and they thereby integrate sig‐
nals from the MAP kinase and mTOR pathways (Hannan et al., 2003; 
Mayer, Zhao, Yuan, & Grummt, 2004; Zhao, Yuan, Frödin, & Grummt, 
2003). In addition, UBF is activated through interaction with cMyc 
(Poortinga et al., 2004) and inhibited by the Rb (Cavanaugh et al., 
F I G U R E  1   Knockdown of LSG1 inhibits NMD3 release from the ribosomal 60S subunit. (a) Schematic of the late cytoplasmic reactions 
of 60S subunit maturation. The cytoplasmic pre‐60S subunit carries the anti‐association factors eIF6 and NMD3. Recruitment of the factor 
SBDS and the GTPase EFL1 leads to eviction of eIF6 in a reaction catalysed by hydrolysis of GTP. SBDS stimulates GTP hydrolysis by EFL1, 
which induces a rotation in the structure of SBDS, resulting in conformational changes and eIF6 release. RPL10 and the GTPase LSG1 then 
bind to the subunit leading to eviction of NMD3, again catalysed by GTP hydrolysis. RPL10 is retained on the 60S subunit, and the mature 
80S ribosome is formed. (Adapted from Finch et al., 2011 and Hedges et al., 2005) (b) Western blot analysis shows the knockdown of LSG1 
in HEK 293 cells. The asterisk denotes a nonspecific band. RPL28 was used as a reference protein. A blot for NMD3 in IMR90 cells with β‐
actin as control is also shown. (c) Western blot analysis shows the levels of NMD3 and RPS14 across sequential fractions (5–10) collected 
from sucrose gradients in control and shLSG1 conditions. Extracts were normalized by spectrophotometry at 254 nm prior to loading. The 
NMD3 in fraction 8 corresponds to the localization of 60S monomers. (d) Immunostaining for NMD3 in MRC5 cells (control and shLSG1), 
followed by confocal microscopy, reveals relocalization of NMD3 to the cytoplasm following LSG1 knockdown. Scale bar: 50 μm
(a)
(b)
(d)
(c)
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1995; Voit, Schäfer, & Grummt, 1997) and p53 (Budde & Grummt, 
1999; Zhai & Comai, 2000) pathways. Accordingly, deregulation 
of ribosome biogenesis is commonly seen in cancer and the histo‐
chemical AgNOR test (for silver‐binding ArGyrophilic Nucleolar 
Organiser Regions) is used for staging and prognosis in many cases 
(Pich, Chiusa, & Margaria, 2000). The increased ribosome biogenesis 
observed in cancer has encouraged the idea that inhibition of this 
process could represent a therapeutic strategy in cancer therapy. 
Indeed, a small‐molecule inhibitor of RNA polymerase I, CX‐5461, 
has shown promise in this regard (Bywater et al., 2012; Drygin et 
al., 2011).
We identified the GTPases involved in the cytoplasmic matura‐
tion of the 60S ribosomal subunit as plausible targets for therapeutic 
intervention. These GTPases catalyse the release of two anti‐associ‐
ation factors that are loaded onto the 60S particle in the nucleus and 
that are removed in the cytosol at the last stages of 60S maturation 
(Finch et al., 2011; Lo et al., 2010; Figure 1a). EFL1 leads to eviction 
of the anti‐association factor eIF6 from the immature pre‐60S in a 
reaction that requires the SBDS cofactor and GTP hydrolysis (Finch 
et al., 2011), whilst LSG1 catalyses the eviction of the anti‐associa‐
tion factor NMD3 in a reaction requiring RPL10, which stays associ‐
ated with the ribosome (Hedges, West, & Johnson, 2005; Ma et al., 
2017; Malyutin, Musalgaonkar, Patchett, Frank, & Johnson, 2017). 
Following removal of eIF6 and NMD3, the mature 60S subunit can 
then join the translating pool of ribosomes and both anti‐associa‐
tion factors are returned to the nucleus to participate in subsequent 
rounds of 60S biogenesis.
Here, we report that knockdown of LSG1 and other components 
of the 60S maturation pathway promotes a robust activation of cel‐
lular senescence. This senescence response is characterized by ac‐
tivation of the p53 and p16/Rb pathways and by a highly restricted 
SASP lacking the NF‐κB‐driven pro‐inflammatory cytokines and 
chemokines. shLSG1 also promotes a striking upregulation of the 
cholesterol biosynthesis pathway and genes involved in endoplasmic 
reticulum (ER) organization, and this is accompanied by a disruption 
of the reticular morphology of the ER. Indeed, RPL10 and LSG1 have 
been shown to associate with ribosomes at the rough ER (Loftus, 
Nguyen, & Stanbridge, 1997; Reynaud et al., 2005) and our data sug‐
gest that loss of LSG1 significantly impacts upon ER homeostasis. 
Finally, we provide evidence that inhibition of 60S maturation can 
restore a senescence response in oncogene‐transformed cells that 
have already bypassed oncogene‐induced senescence (OIS).
2  | RESULTS
2.1 | Knockdown of LSG1 inhibits NMD3 release 
from the ribosomal 60S subunit
The enzymes that catalyse the final cytoplasmic reactions in the 
maturation of the large (60S) ribosomal subunit (Figure 1a) represent 
possible targets for therapeutic inhibition. Accordingly, we chose 
RNAi rather than gene deletion as a strategy to mimic pharmaco‐
logical inhibition because it can be efficient, yet not absolute. Since 
LSG1 catalyses the release of NMD3 from the cytoplasmic pre‐60S 
particle, knockdown of LSG1 should result in failure to release NMD3 
and therefore to its cytosolic sequestration (Hedges et al., 2005; Ma 
et al., 2017; Malyutin et al., 2017). Infection of cells with a lentivi‐
ral vector encoding a shRNA to LSG1 led to efficient knockdown 
of the protein, as assessed by Western blot (Figure 1b). Knockdown 
of LSG1 resulted in minimal upregulation of NMD3 (Figure 1b), but 
rather to an increase in association of NMD3 with the 60S subunit 
fraction as assessed by sucrose density gradient separation of ribo‐
somal subunits (Figure 1c). NMD3 is loaded onto pre‐60S subunits in 
the nucleus (Gadal et al., 2001; Ho, Kallstrom, & Johnson, 2000), and 
immunofluorescent staining of control cells showed a nuclear/nucle‐
olar staining pattern for NMD3 (Figure 1d). Knockdown of LSG1 led 
to relocalization of NMD3 to the cytoplasm (Figure 1d), consistent 
with its retention on maturing cytoplasmic pre‐60S particles due to 
loss of LSG1‐mediated release. This relocalization of Nmd3 from nu‐
cleus to cytoplasm is also observed in yeast lacking Lsg1 (Hedges et 
al., 2005) and is diagnostic of the defect in this maturation reaction.
2.2 | Impairment of 60S maturation triggers a 
robust cellular senescence response
We generated additional shRNAs to SBDS (the cofactor for EFL1 
(Finch et al., 2011)) to target 60S maturation and assessed their 
knockdown by Western blot: we obtained two shRNAs that were ef‐
ficient for SBDS (Figure 2a). We introduced the shRNAs into primary 
human MRC5 fibroblasts through lentiviral transduction to impair 
60S maturation and assessed their growth. Several days after viral in‐
fection, we noticed that impairment of 60S maturation led to a sparse 
culture and spreading of the cells with morphology that resembled 
cellular senescence. Analysis of BrdU incorporation using high con‐
tent microscopy revealed that knockdown of LSG1 and SBDS led to 
a cell cycle arrest (Figures 2b and S1a) and this was accompanied by 
activation of acidic β‐galactosidase activity and accumulation of p16 
mRNA and protein (Figures 2c, S1a,b and S2a), indicating a senes‐
cence response. In addition, we also observed increased staining for 
p53, p21 and the DNA damage response marker pST/Q (Figures S1a 
and S2b). Furthermore, although the shSBDS(b) shRNA gave a less 
robust response with p53 and p21 immunofluorescence, p21 mRNA 
was induced consistent with activation of the p53 pathway (Figure 
S2a,b). Although activation of the p53 pathway can lead to apoptosis 
under certain circumstances, we observed no induction of apoptosis 
by knockdown of LSG1 (Figure S2c). Senescence is characterized by 
ongoing, rather than transient, growth arrest, and we confirmed the 
continuous nature of the shLSG1‐induced growth defect through as‐
sessment of BrdU incorporation and p16, p53 and p21 immunoreac‐
tivity in a time course over 15 days (Figures 2d and S2d). To confirm 
the specificity for LSG1 in this process, we first generated and uti‐
lized a second shRNA to LSG1 (Figure S3a) and again observed in‐
duction of acidic β‐galactosidase activity (Figure S3b) and reduction 
in BrdU staining (Figure S3c). Next, we used siRNA SMARTpools to 
EFL1 and LSG1 (Figure S4a) and observed the expected reduction in 
BrdU incorporation (Figure S4b), induction of acidic β‐galactosidase 
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activity (Figure S4c) and induction of p16 immunoreactivity (Figure 
S4d). Deconvolution of the LSG1 siRNA pools revealed two inde‐
pendent siRNAs that knocked down LSG1 (Figure S5a), reduced 
BrdU incorporation, and induced p16 and p53 (Figure S5b). Taken 
together, these results demonstrate that inhibition of 60S ribosomal 
subunit maturation triggers a robust cellular senescence response.
2.3 | The senescence response to inhibition of 60S 
maturation is p53‐dependent in primary cells
The two main pathways that implement most aspects of replicative 
and oncogene‐induced senescence responses are the p16/retinoblas‐
toma (RB) and p53 pathways (Salama, Sadaie, Hoare, & Narita, 2014). 
As described above, we observed that both pathways were acti‐
vated by knockdown of LSG1 and we set out to determine which of 
these pathways was required for induction of senescence under this 
condition. The viral oncoproteins E6 and E7 from the human papillo‐
mavirus inhibit the p53 and Rb pathways, respectively, and are well‐
established tools for the determination of function of these pathways 
(Boulet, Horvath, Vanden, Sahebali, & Bogers, 2007). We infected pri‐
mary human fibroblasts with retroviral vectors expressing E6, E7 or 
an E6‐E7 fusion protein (Acosta et al., 2008) and then with lentiviral 
shRNA to LSG1. Both viral constructs were functional since expres‐
sion of E6 abrogated p53 expression, whilst E7 expression enhanced 
p53 levels as previously described (Demers, Halbert, & Galloway, 1994; 
Figure 3a). Loss of p53 function leads to bypass of replicative and on‐
cogene‐induced senescence (Bond, Wyllie, & Wynford‐Thomas, 1994; 
Serrano, Lin, McCurrach, Beach, & Lowe, 1997), and similarly, E6 ex‐
pression led to maintained BrdU incorporation upon LSG1 knockdown 
(Figure 3b), indicating p53 dependence. Expression of E7, on the other 
F I G U R E  2   Knockdown of LSG1 and SBDS induces senescence. (a) Western blot showing the efficiency of LSG1 and SBDS knockdown in 
MRC5 cells induced by the hairpins shLSG1, shSBDS(a) and shSBDS(b). The asterisk denotes a nonspecific band in the LSG1 blot. RPL28 was 
used as a reference protein. (b) High content imaging analysis of BrdU incorporation and immunostaining in MRC5 cells with LSG1 and SBDS 
downregulation, 7 days postinfection. The cells were treated with 50 mM BrdU for 16 hr. (c) The senescence‐associated β‐galactosidase 
assay was performed 7 days postinfection. Images were taken using phase contrast microscopy, and the number of cells that were positive 
for the blue precipitate was counted. The bar chart on the right shows high content imaging analysis of p16 immunostaining. Ras‐transduced 
cells were used as a positive control for p16 induction. (d) Time course experiment (time points: d0, d2, d5, d8, d11, d14) using a siRNA 
SMARTpool for LSG1 (siLSG1p). Cell growth (DAPI stain), BrdU incorporation and p16 expression were monitored throughout the time 
course using high content microscopy. Error bars show standard deviation of 3 biological replicates. Statistical significance was calculated 
using one‐way ANOVA with Dunnett's (Figure 2b,c) or Sidak's (Figure 2d) multiple comparisons tests. *p < 0.05, **p < 0.01, ***p < 0.001, and 
****p < 0.0001
(a)
(c)
(d)
(b)
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hand, did not rescue the inhibition of cell cycle elicited by LSG1 knock‐
down. We confirmed the p53 dependence of the senescence response 
using a C‐terminal, dominant‐negative fragment of p53, which leads to 
stabilization of the endogenous p53 protein through inhibition of its 
function (Figure 3c). Once again, inhibition of the p53 pathway led to 
bypass of shLSG1‐induced proliferative arrest (Figure 3d). Finally, we 
used shRNA to p53 to follow the growth characteristics of cell lines 
transduced with shRNA to LSG1 (Figure 3e). p53 knockdown resulted 
in greatly accelerated growth rates in vector control cells, and the 
knockdown of LSG1 failed to inhibit growth in these cells (Figure 3f).
2.4 | Knockdown of LSG1 induces a senescent 
transcriptional response
The transcriptional responses to several triggers of senescence have 
recently been reported (Acosta et al., 2013, 2008; Hoare et al., 2016; 
Muñoz‐Espín et al., 2013). Therefore, in order to gain mechanistic in‐
sight into the molecular cause of the senescence elicited by inhibition 
of 60S maturation, we performed transcriptomic analysis of shLSG1 
cells. In particular, we sought to investigate molecular signatures that 
were shared with other forms of senescence. Senescence was induced 
in primary human MRC5 fibroblasts through transduction of shLSG1 
and through overexpression of K‐RasG12V as a positive control for 
oncogene‐induced senescence. Extraction of RNA was followed by 
AmpliSeq library preparation and IonTorrent sequencing of amplicons, 
and the differential expression of cells expressing shLSG1, oncogenic 
K‐RasG12V and control was analysed (Figure 4a and Data S1). Global 
gene expression clustering revealed clear differences between the two 
senescent states (Figure 4a), and we therefore assessed enrichment of 
the signature of 253 genes induced by LSG1 knockdown (Figure 4a and 
Data S2) in the transcriptomes of previously reported triggers of senes‐
cence. We interrogated preranked gene expression lists from several 
F I G U R E  3   The senescence response induced by LSG1 knockdown is p53‐dependent. (a) Western blots for LSG1, p53 and RPL28 in 
MRC5 cells transduced with shLSG1 and/or HPV E6, E7 or E6E7 (the asterisk denotes a nonspecific band). (b) BrdU incorporation was 
measured by high content imaging in cells transduced as in (a) above. K‐RASG12V‐transduced cells were used as a positive control for growth 
arrest. (c) Western blots for LSG1, p53 and RPL28 in MRC5 cells transduced with shLSG1 and/or a dominant‐negative p53 construct (dn‐
p53) (the asterisk denotes a nonspecific band). Ras retroviral overexpression is included as a positive control. (d) BrdU incorporation was 
measured by high content imaging in cells transduced as in (c) above. (e) qRT–PCR analysis of MRC5 cells transduced with shLSG1 and/
or shp53 for the quantification of p53 transcript levels. (f) Time course experiment for the study of the growth levels of the above (e) cells, 
using high content imaging to measure DAPI stain. Time points: d0, d2, d5, d8, d11, d14. Error bars show standard deviation of 3 biological 
replicates. Statistical significance was calculated using two‐tailed t tests or one‐way ANOVA with Dunnett's (Figure 3b) or Sidak's (Figure 3f) 
multiple comparisons tests. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001
(a)
(c)
(e) (f)
(d)
(b)
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systems in which senescence was induced, including OIS (Acosta et 
al., 2013; Pawlikowski et al., 2013), replicative senescence (Pazolli et 
al., 2009), paracrine senescence (Acosta et al., 2013), drug‐induced 
senescence (Jing et al., 2011) and pancreatic intraepithelial neoplasia 
(Ling et al., 2012). The preranked lists of genes were used to perform 
gene set enrichment analysis (GSEA) of the 253 genes induced by 
shLSG1 and in almost all cases showed enrichment with a false dis‐
covery rate‐adjusted (FDR) Q‐value of 0.01 or below (Figure 4b). The 
two exceptions that did not show statistically significant enrichment 
were developmental senescence (Muñoz‐Espín et al., 2013) and DNA 
damage‐induced senescence in hepatic stellate cells (Krizhanovsky 
et al., 2008; Figure 4c). Thus, the transcriptional response to LSG1 
knockdown contains a strong senescent signature that is shared with 
multiple forms of senescence that arise in vitro and in vivo.
2.5 | Knockdown of LSG1 induces production of a 
restricted SASP
As expected, we observed a marked antiproliferative signature 
characterized by upregulation of CDK inhibitors and downregu‐
lation of E2F1, cyclins and cyclin‐dependent kinases (Figure 5a). 
One of the hallmarks of senescent cells is the release of a cock‐
tail of pro‐inflammatory cytokines and chemokines, collectively 
termed the SASP. We analysed our transcriptomic data in more 
F I G U R E  4   A signature of genes 
induced by LSG1 knockdown is common 
with other senescence responses: (a) 
Hierarchical clustering of mRNA profiles 
from cells transduced with K‐RASG12V, 
shLSG1 and vector control (Cont.) in 
MRC5 cells showing genes changing 
significantly (Adj.p < 0.01) between 
shLSG1 and control (GSE128055). A 
signature of 253 genes induced by 
shLSG1 is highlighted. Data represent 3 
experimental replicates. (b) GSEA plots 
showing that a signature of 253 genes 
derived from MRC5 cells undergoing 
shLSG1‐induced senescence (described 
in a.) is significantly enriched in multiple 
forms of senescence. (q represents false 
discovery rate (FDR)). (c) GSEA plots 
showing that a signature of 253 genes 
derived from MRC5 cells undergoing 
shLSG1‐induced senescence (described 
in a.) is not significantly enriched 
during developmental senescence or 
DNA damage‐induced senescence. (q 
represents false discovery rate (FDR))
(a)
(b)
(c)
F I G U R E  5   Transcriptomic analysis reveals a robust senescent transcriptional response with a restricted SASP upon LSG1 knockdown. 
(a) Regulation of antiproliferative and proliferative cell cycle‐related transcripts by shLSG1 in MRC5 cells. (b) Clustering of transcript levels 
of SASP factors. (c) Cluster 2 contains a set of mRNAs that are specific for shLSG1 (vs. K‐RASG12V) that includes TGFB2 and related genes. 
Cluster 3, region A is OIS‐specific and is comprised of NF‐κB‐driven canonical SASP genes. (d) GSEA of the transcriptome of MRC5 cells 
transduced with shLSG1 compared to control showing significant enrichment for the TGFB signalling pathway (KEGG pathway) and no 
significant enrichment for the OIS‐associated NF‐κB signature (Chien et al., 2011) (e) qPCR analysis of the above cells for the quantitation 
of IL‐1α, IL‐1β and IL‐8 transcript levels. (f) High content imaging analysis of the SASP factors IL‐1α, IL‐1β, IL‐6 and IL‐8. KRASG12V retroviral 
overexpression was included as a positive control. Error bars show standard deviation of 3 biological replicates
     |  7 of 18PANTAZI eT Al.
(a)
(c)
(d)
(e) (f)
(b)
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detail for genes previously identified as SASP‐related or gener‐
ally involved in inflammation (Acosta et al., 2013). This analysis 
revealed a lack of most of the canonical SASP factors involved 
in OIS and revealed three distinct gene clusters (Figure 5b)—in‐
cluding one that was upregulated upon LSG1 knockdown but 
only weakly (or not at all) with OIS (Figure 5c, cluster 2) and one 
specific for OIS (Figure 5c, cluster 3). The shLSG1‐specific clus‐
ter (cluster 2) included TGFβ2 and TGFβR1 as well as the other 
TGFβ family receptors ACVR1 and ACVR2a and the TGFβ target 
genes SERPINE1 and IGFBP7 (Figure 5c). This was supported by 
gene set enrichment analysis, which indicated significant en‐
richment of genes associated with the TGFβ signalling pathway 
(Figure 5d) and qRT–PCR analyses that verified upregulation of 
SERPINE1, TGFB2 and IGFBP7 (Figure S6a). The OIS‐specific tran‐
scriptome cluster included strongly pro‐inflammatory cytokines 
and chemokines (Figure 5c, cluster 3, region A), indicative of the 
strong NF‐κB‐driven SASP program in OIS. Gene set enrichment 
analysis between the shLSG1 transcriptome and the OIS NF‐κB 
programme showed no significant induction of these genes upon 
knockdown of LSG1 (Figure 5d), and this lack of key NF‐κB‐driven 
SASP components was confirmed at the mRNA (Figure 5e) and 
protein (Figure 5f) levels. Thus, impairment of 60S matura‐
tion through LSG1 knockdown elicits a restricted SASP centred 
around TGFβ/activin signalling.
2.6 | Increased translation coincident with 
senescence occurs in cells with knockdown of LSG1
Since LSG1 catalyses a key step in the maturation of the 60S ri‐
bosomal subunit, a possible mechanism for generation of stress 
leading to senescence could be a lack of 60S subunits and con‐
sequent translational insufficiency. We transduced cells with 
vector, shLSG1 or KRasG12V, awaited the onset of senescence 
and then performed polysome profiling to assess the ribosomal 
composition of the cells. We observed no qualitative differences 
between the conditions, except perhaps for a marginal reduc‐
tion in peak height for the 60S subunit upon shLSG1 transduc‐
tion (Figure 6a), suggesting that senescence occurred well before 
impairment of 60S maturation could affect overall polysomal 
composition. We also employed qRT–PCR for the 18S and 28S 
rRNAs to quantify differences in total ribosomal subunit com‐
position, and once again, we found no significant change in ei‐
ther subunit upon knockdown of LSG1, despite confirmation of 
onset of senescence by induction of TGFB2 and p21 (Figure 6b). 
In order to assess the impact on translation, we used O‐propargyl 
puromycin (OPP) to label actively translating ribosomes and we 
quantified OPP incorporation by high content microscopy. Rather 
than causing a reduction, knockdown of LSG1 gave rise to an ele‐
vated translation rate (Figure 6c). Oncogene‐induced senescence 
induced by H‐RasG12V also led to increased translation, consist‐
ent with previous reports that senescence is a cellular state as‐
sociated with high translational and metabolic activity (Dörr et 
al., 2013; Herranz et al., 2015; Laberge et al., 2015; Narita et al., 
2011). We harvested the polysomal fractions from our profiling 
experiment and performed qRT–PCR to assess whether mRNAs 
involved in the senescence response were being actively trans‐
lated. As expected, polysome‐associated mRNAs for p16 and p21 
were elevated in both of the senescent conditions, whereas IL‐1α, 
the master regulator of the SASP (Laberge et al., 2015), was asso‐
ciated with polysomes in the OIS sample alone (Figure 6d). Thus, 
the senescence response to impairment of 60S ribosomal subunit 
maturation is not triggered by ribosome depletion or translational 
insufficiency.
2.7 | 60S inhibition leads to disruption of ER 
homeostasis and morphology
In addition to the targeted analyses of transcriptomic data de‐
scribed above, we utilized global GSEA to shed light upon the 
cellular response to LSG1 knockdown. This analysis revealed a 
striking upregulation of processes that occur at the ER (top five 
processes shown in Figure 7a), in particular the cholesterol bio‐
synthesis pathway (Figure 7b). Indeed, 7 of the top 25 upregu‐
lated genes in our analysis encoded members of the cholesterol 
synthesis pathway and almost every member of the pathway 
was upregulated (Figure S6b). We also confirmed upregulation of 
squalene epoxidase (SQLE) and hydroxymethylglutaryl‐CoA syn‐
thase (HMGCS1) protein (Figure 7c). We were unable to assess the 
contribution of the cholesterol biosynthesis pathway to the in‐
duction of senescence as dual knockdown of LSG1 and individual 
cholesterol biosynthesis genes was toxic to the cells. The strik‐
ing enrichment of the cholesterol biosynthesis and other ER‐re‐
lated pathways in shLSG1‐induced senescence led us to look more 
closely at the morphology of the ER. LSG1 has been reported to 
predominantly localize to the ER (Reynaud et al., 2005), and its re‐
action partner RPL10 (also known as QM protein) has been shown 
to interact with ER‐associated ribosomal particles (Loftus et al., 
1997). Immunofluorescent staining for the ER marker calnexin 
revealed the expected reticular morphology of the ER in con‐
trol cells, but in shLSG1 cells where NMD3 was cytoplasmic, the 
F I G U R E  6   Knockdown of LSG1 does not inhibit global translation. (a) Polysome profiling of MRC5 cells at senescence triggered by 
shLSG1 or K‐RASG12V after 7 days. (b) qPCR analysis of the above cells for the quantitation of ribosomal 18S and 28S transcript levels to 
assess total ribosomal subunit composition, alongside TGFB2 and p21 confirming the senescence response. (c) Analysis of translational 
activity using O‐propargyl puromycin (OPP) and high content imaging. Quantitation of mean cell average intensity from images obtained. 
Representative images are provided. Scale bar: 200 μm. (d) qPCR analysis of polysome‐associated transcripts for the senescence markers 
p16, p21 and IL‐1α. Error bars show standard deviation of 3 biological replicates. Statistical significance was calculated using two‐tailed t 
tests or one‐way ANOVA with Dunnett's multiple comparisons tests (Figure 6c,d). *p < 0.05 **p < 0.01, ***p < 0.001, and ****p < 0.0001
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ER appeared highly fragmented and punctate (Figure 7d,e). We 
quantified this effect using the MiNA plugin for ImageJ (Valente, 
Maddalena, Robb, Moradi, & Stuart, 2017) which analyses reticu‐
larity of cellular features. Upon knockdown of LSG1, we observed 
a reduction in ER footprint, number of individual ER components 
and number of ER networks, indicating a marked disruption of ER 
morphology (Figure 7f). Thus, knockdown of LSG1 leads to disrup‐
tion of ER homeostasis and morphology.
2.8 | The cholesterol biosynthetic and ER  
transcriptomic programmes are common 
to the senescence induced by inhibition of 60S 
maturation and OIS
Oncogene‐induced senescence is driven by multiple cellular stress 
responses, including replication stress and DNA damage, metabolic 
and oxidative stresses (reviewed in Kuilman, Michaloglou, Mooi, 
and Peeper (2010)). We wished to ascertain whether we could de‐
tect signals of a stress response in our transcriptomic data that 
were conserved between shLSG1‐induced and oncogene‐induced 
senescence (OIS). We therefore compared the transcriptomes of 
cells that underwent senescence due to knockdown of LSG1 or OIS 
induced by K‐RasG12V to find genes that were upregulated in both 
cases. We found 125 genes upregulated in common between the 
two senescent programmes (Figure 8a), and we subjected these 
genes to gene ontology analysis. Strikingly, by far the most sig‐
nificant signature that emerged (Figure 8b) was cholesterol bio‐
synthesis (p‐value = 1.13 × 10−9), followed by ER compartment 
(p‐value = 8.73 × 10−4). Since the gene sets for ER include most of 
the genes involved in cholesterol biosynthesis, the predominant 
shared component of the senescent transcriptomic response is an 
induction of cholesterol biosynthesis. We found that almost every 
gene in the cholesterol biosynthesis pathway was upregulated in 
both forms of senescence (Figure 8c), suggesting that the path‐
way may be of functional importance in the senescence response. 
We therefore undertook a restricted cholesterol biosynthetic 
siRNA screen for bypass of OIS, which we defined as an increase 
of 30% in BrdU incorporation compared to the senescent state. 
Several siRNAs from the pathway bypassed OIS (Figure S7a) and 
the three strongest candidates from the screen (MSMO1, MVD and 
DHCR7) showed robust and significant bypass of OIS (Figures 8d 
and S7b). Thus, activation of the cholesterol biosynthesis pathway 
is a tumour‐suppressive response that contributes to senescence 
induced by perturbation of 60S maturation and oncogenic Ras.
2.9 | shLSG1 amplifies the cholesterol biosynthesis 
signature and induces senescence in cells that have 
bypassed OIS
A critical step in the transformation of cells expressing oncogenic 
Ras is the bypass of OIS through disruption of the p53 or RB path‐
ways (Serrano et al., 1997). One (or both) of these canonical tu‐
mour‐suppressive pathways is inactivated in most cancers, and 
thus, for a prosenescent cancer therapy to be effective, it should 
be able to elicit tumour suppression independently of these two 
pathways. We wished to assess whether the induction of the cho‐
lesterol biosynthesis programme by inhibition of 60S maturation 
might provide such a tumour‐suppressive response. We therefore 
generated pretransformed cells through a combination of overex‐
pression of H‐RasG12V and the human papillomavirus oncoproteins 
E6, E7 or an E6‐E7 fusion and then performed knockdown of LSG1. 
We observed that knockdown of LSG1 reduced cell content in the 
absence or presence of oncogenic Ras and that E6, E7 and E6‐E7 
bypassed Ras‐induced growth arrest (Figures 8e and S7c), as ex‐
pected. In the conditions where OIS was bypassed, shLSG1 elicited a 
marked growth arrest, even in the E6E7 line where both p53 and RB 
pathways are defective (Figures 8e and S7c). This growth arrest was 
accompanied by induction of the cholesterol biosynthesis pathway 
(shown for HMGCS1 and MSMO1 in Figure 8f), and acidic β‐galac‐
tosidase staining indicated that the reduced cell number was due to 
a senescence response (Figure S7d). More detailed analysis of the 
Ras/E6E7 cells revealed that although the cholesterol biosynthesis 
genes MSMO1, HMGCS1, SQLE and FDFT1 were already induced 
by Ras, shLSG1 led to their further induction (Figures 8g and S7e). 
p21 was not induced, due to p53 inactivation by E6, but notably, 
shLSG1 led to a reduction in levels of IL1B and IL8. Taken together, 
these data reveal that inhibition of 60S maturation elicits a p53‐in‐
dependent senescence response in cells that have bypassed OIS and 
simultaneously restricts the potent pro‐inflammatory SASP driven 
by oncogenic Ras.
3  | DISCUSSION
Here, we show that inhibition of 60S maturation leads to a robust 
induction of cellular senescence that is associated with perturbation 
of ER homeostasis and that this can elicit tumour suppression even 
in cells with bypass of OIS. The impairment of 60S ribosomal subunit 
maturation upon knockdown of LSG1 was verified by relocalization 
F I G U R E  7   Knockdown of LSG1 leads to upregulation of cholesterol biosynthesis pathways and homeostatic alterations in the ER 
apparatus. (a) Gene set enrichment analysis (GSEA), ranked by normalized enrichment score (NES), revealed the top 5 upregulated biological 
processes as a result of LSG1 knockdown. The false discovery rate (FDR) yields the Q‐value for statistical significance. (b) GSEA diagram 
of the cholesterol biosynthesis signature upon LSG1 knockdown as described in (a). (c) Western blot for LSG1, RPL28 and the cholesterol 
biosynthesis enzymes SQLE and HMGCS1 in shLSG1‐transduced MRC5 cells. (d) Immunofluorescence staining for calnexin in MRC5 cells 
transduced with control and with shLSG1, imaged by confocal microscopy. Scale bar: 50 μm. (e) High magnification images of the regions 
indicated in (d) stained for calnexin. (f) FIJI‐based analysis of the ER skeleton in the cells above, using the MiNA plugin (Valente et al., 2017). 
Error bars denote SEM of three biological replicates. Statistical significance is calculated using two‐tailed t tests. *p < 0.05, **p < 0.01, and 
***p < 0.001
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of NMD3 to the cytoplasm in analogous fashion to the response to 
disruption of Lsg1 in Saccharomyces cerevisiae (Hedges et al., 2005). 
However, rather than causing accumulation of pre‐60S subunits and 
decreased polysomes as in S. cerevisiae, it resulted in an increase 
in translation accompanied by normal ribosome content, consist‐
ent with previous reports of senescence as a highly metabolically 
active process requiring elevated rates of translation (Dörr et al., 
2013; Narita et al., 2011). Similarly, deletion of Sbds in normal mouse 
(a)
(d)
(e)
(f)
(b) (c)
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pancreas was recently shown to elicit a senescent response with‐
out perturbation of global ribosome content (Tourlakis et al., 2015), 
whilst the equivalent perturbation in S. cerevisiae promotes impair‐
ment of the polysome profile (Menne et al., 2007). Taken together, 
these reports suggest that an important function of the senescence 
response may be to halt cellular proliferation prior to the onset of a 
translational defect, thereby protecting cellular translational capac‐
ity in response to perturbations of ribosome maturation. S. cerevisiae 
lacks the ability to mount complex stress responses such as senes‐
cence, and therefore, these 60S defects result in catastrophic reduc‐
tion of ribosome content.
Senescence is a pleiotropic response to many cellular stresses, 
and although many of the effector pathways (e.g., cell cycle ar‐
rest and the SASP) are well characterized, the precise molecu‐
lar mechanisms that trigger senescence remain obscure in most 
cases. Transcriptomic analyses can shed light upon molecular 
mechanisms of cellular stresses because discrete effector path‐
ways often reveal the nature of the initial stress, for example the 
induction of NRF2 gene targets in response to oxidative stresses 
(reviewed in Nguyen, Nioi, and Pickett (2009)) and HIF1 gene tar‐
gets upon hypoxia (reviewed in Kaluz, Kaluzová, and Stanbridge 
(2008)). Our transcriptomic analyses gave a clear indication of 
stress arising at the ER, and our further analyses revealed disrup‐
tion of ER morphology upon loss of LSG1. The origin of a cellular 
stress response at the ER is consistent with previous reports of 
LSG1 and RPL10 localization and function at the ER (Loftus et al., 
1997; Reynaud et al., 2005). It is unlikely that the LSG1‐/RPL10‐
mediated removal of NMD3 only occurs at the ER and we favour a 
model whereby this reaction occurs throughout the cytosol and at 
the ER, but the stress response arises due to perturbation of the 
latter. At this time, it is unclear why there is such a specific activa‐
tion of the cholesterol biosynthesis pathway by shLSG1 and why 
this signature is also so prevalent in OIS.
A recent study identified accumulation of the ribosomal 40S sub‐
unit protein RPS14 as a mechanism contributing to senescence in 
response to multiple stimuli (Lessard et al., 2018). Unlike our p53‐
dependent response, the response to RPS14 was Rb‐dependent, 
indicating that it is mechanistically distinct. Although the p53 path‐
way is required for the induction of senescence upon knockdown 
of LSG1 in primary human fibroblasts, we observed a strong se‐
nescence response in cells transformed with Ras/E6E7, despite the 
absence of p53 activity. Ras‐induced senescence is associated with 
enhanced intracellular metabolic activity through several pathways 
(Dörr et al., 2013; Herranz et al., 2015; Laberge et al., 2015; Narita 
et al., 2011), and whilst E6E7 relieves the proliferative block, it en‐
hances the SASP and may elevate levels of metabolic stresses. We 
suggest that knockdown of LSG1 in such cells may compound these 
stresses, leading to the induction of a p53‐independent senescence 
response. Indeed, the cholesterol biosynthesis signature is induced 
by Ras and then further enhanced by knockdown of LSG1, perhaps 
reflecting enhanced metabolic stress arising at the ER. Overall, an 
emerging picture is that cells use multiple mechanisms to surveil ri‐
bosome biogenesis and that senescence is the outcome when de‐
fects are detected.
The inhibition of 60S ribosomal subunit maturation gives rise to a 
robust senescence response that is comparable with the OIS induced 
by oncogenic Ras in all aspects that we examined except for the SASP. 
The SASP elicited by deregulation of Ras in fibroblasts is a cocktail of 
pro‐inflammatory cytokines and chemokines resembling those pro‐
duced during an immune response to infection. On the other hand, the 
restricted SASP activated upon inhibition of 60S maturation primarily 
involves components of the TGFβ signalling pathway. Furthermore, 
in Ras/E6E7 cells, where the SASP is elevated, knockdown of LSG1 
reduced the expression of markers of the SASP. In terms of a potential 
cancer therapy, inhibition of the strongly pro‐inflammatory SASP is 
likely to be a considerable advantage, since pro‐inflammatory signal‐
ling, through IL‐6 in particular, has been linked to tumour progression 
and metastasis (He et al., 2013; Kim et al., 2009).
A therapeutic concept that is supported by our data is that inhibi‐
tion of ribosome biogenesis could be an effective cancer therapy and 
our induction of tumour suppression in transformed cells with defec‐
tive p53 and RB pathways is particularly encouraging. GTPases have 
not previously been strong candidates for inhibition through small 
molecules, although the translational GTPase eEF2, a homologue of 
F I G U R E  8   LSG1 targeting restores the cholesterol/ER senescent programme in H‐RASG12V‐expressing cells that have bypassed 
senescence. (a) Venn diagram representing the number of genes commonly induced between shLSG1 knockdown induced senescence and 
OIS in MRC5 cells by AmpliSeq transcriptome analysis. (b) Bar graph representing the p‐value after functional annotation analysis of the 
most significant GO terms enriched in the 125 genes induced by shLSGI and oncogenic RAS in MRC5 cells as in a. Analysis was performed 
using the DAVID web resource. (c) Heat map representing mRNA fold change (Log2 scale) in the AmpliSeq expression profile of cholesterol 
biosynthesis genes in shLSG1‐ and RAS‐transduced MRC5 cells. Each sample represents the mean of 3 experimental replicates. Bold 
character genes represent significant changes in expression in both conditions. (d) BrdU proliferation assay of IMR90 ER:RAS or ER:Stop 
control cells 5 days after 4 hydroxytamoxifen (4OHT) treatment and siRNA SMARTpool transfection for the cholesterol biosynthesis 
genes MSMO1, MVD, DHCR7 and TP53 (as a positive control). Nontargeting (NT) siRNA SMARTpool was used as a negative control. Bars 
represent the mean of 3 experimental replicates. Error bars represent the SEM. (e) Proliferation assay showing relative cell content of cells 
transduced with shLSG1 (L) or control (C) lentiviral vectors in cells bypassing OIS. Bypass of OIS was achieved with retrovirus expressing 
HPV proteins E6, E7, E6E7 or neomycin control. Cells were seeded at low density, cultured for 14 days and stained with crystal violet (CV) 
as indicated. Bars represent the mean quantification of CV staining of three independent experiments. Error bars represent the SEM. (f) 
Heat map showing HMGCS1 and MSMO mRNA fold change (Log10 scale) by qRT–PCR from cells treated as in (e) above: C refers to control; 
L refers to shLSG1. (g) qRT–PCR analysis of IMR90 cells transduced with Vector control, Ras, Ras/E6E7 or Ras/E6E7/shLSG1. MSMO1, p21, 
IL1B and IL8 were measured. Statistical significance was calculated using two‐tailed t tests or one‐way ANOVA with Dunnett's multiple 
comparisons tests (Figure 8d). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001
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EFL1, has been well validated as an inhibitory target since the nat‐
urally occurring inhibitors sordarin, diphtheria toxin and exotoxin A 
all target this enzyme. Inhibition of eEF2 is toxic to mammalian cells 
due to inhibition of translation, but here, we demonstrate that in‐
hibition of LSG1, and possibly EFL1 by extension, may provide an 
effective prosenescent cancer therapy with lesser side effects since 
translation remains unimpaired. Recently, an important advance in 
the field of GTPase inhibition was reported with the identification 
of a non‐nucleotide active site inhibitor of the small GTPase Rab7 
that can act as a scaffold for derivatization to produce inhibitors of 
other GTPases (Agola et al., 2012; Hong et al., 2015). Accordingly, 
the translational GTPases of 60S ribosomal subunit maturation may 
be amenable to development of inhibitors. In conclusion, this study 
suggests that the GTPase LSG1 has high potential as a candidate 
target for prosenescent cancer therapy in cases where tumour‐sup‐
pressive senescence is bypassed due to p53 and/or RB deficiency.
4  | METHODS
4.1 | Cell culture
MRC5 and IMR90 early passage primary human fibroblasts were pur‐
chased from the Culture Collection at Public Health England. These 
cells and HEK293ET (used for viral production—a kind gift of Felix 
Randow at the MRC Laboratory of Molecular Biology, Cambridge) were 
cultured in Dulbecco's Modified Eagle's Medium (DMEM—Thermo 
Fisher, 41965) supplemented with 10% foetal bovine serum (FBS—
Thermo Fisher, 10270–106) and 1% penicillin/streptomycin. All cells 
were maintained between 20% and 90% confluence at 37°C, 5% CO2.
4.2 | shRNA design and cloning
The Whitehead Institute for Biomedical Research small interfering 
RNA (siRNA) design tool (http://jura.wi.mit.edu/bioc/siRNA ext/) 
was used to opt for the top‐scoring 21‐mer target sequences for our 
genes of interest. These oligos were run through NCBI's BLAST pro‐
gram to minimize off‐target effects. shRNA design was conducted in 
compatibility with the lentiviral transfer vector pLKO.1. Forward and 
reverse oligos (purchased from Sigma) were annealed and ligated 
into the viral transfer vector and then used to transform competent 
bacteria cells (protocol at: http://www.addge ne.org/tools/ proto 
cols/plko/). Successful clones were identified by restriction diges‐
tion and sequencing.
4.3 | Viral transduction
Lentiviral production for shRNAs was carried out by transfection of 
HEK293ET cells with a packaging vector (psPAX2), VSV‐G envelope 
(pMD2.G) and viral transfer vector (listed below). For retroviral trans‐
duction, pGag‐Pol was used in place of psPAX2. 10 μg of each vector 
was combined with 80 μl of polyethyleneimine (PEI—1 μg/μl) in a 500 μl 
volume (the remainder being DMEM). This was then added to a 75‐
cm2 flask of cells containing 10 ml of DMEM/10% FCS and incubated 
overnight. Medium was exchanged the following day for DMEM/10% 
FCS and left for a further 24 hr at which point the viral supernatant was 
harvested for infection. Viral supernatant was diluted (typically 3:10) 
with DMEM/10% FCS and mixed with polybrene (hexadimethrine 
bromide) at a final concentration of 5 μg/ml. This was filtered through 
a sterile 0.45‐μm filter and used to replace the medium on recipient 
cells. Twenty‐four hours after infection, the virus‐containing medium 
was replaced with fresh medium. Forty‐eight hours after infection, an‐
tibiotic was added for selection, puromycin at 1 μg/ml or blasticidin at 
5 μg/ml, and cells were selected until uninfected control cells had died. 
Time points referred to are days postinfection (not selection).
4.4 | Viral transfer vectors
Knockdown of 60S maturation factors using lentivirus was carried 
out using pLKO1 or TetLKO‐puro containing oligos as follows:
Ctrl: CCGGTCCGCAGGTATGCACGCGTG
LSG1: CCGGTGGGCTACCCTAATGTTGGTACTCGAGTACCAACAT 
TAGGGTAGCCCATTTTTG
SBDS(a): CCGGAAGCTTGGATGATGTTCCTGACTCGAGTCAGGAA 
CATCATCCAAGCTTTTTTTG
SBDS(b): CCGGCTGCTTCCGAGAAATTGATGACTCGAGTCATCA 
ATTTCTCGGAAGCAGTTTTTG
E6, E7 and E6E7 constructs in pLXSN have been previously de‐
scribed (Acosta et al., 2008). Dominant‐negative p53 (GenBank 
KF766124) and KRasG12V were expressed in the retroviral vec‐
tor pM6P‐Blast (a kind gift of Felix Randow, MRC Laboratory of 
Molecular Biology).
4.5 | siRNA transfections
For siRNA transfections, plated cells were treated with a mix of 
medium containing the siRNA SMARTpool or single siRNA at a final 
concentration of 50 nM and 3.5% Hiperfect transfection reagent 
(Qiagen, 1029975). For long‐term silencing, siRNA transfections 
were repeated every 3 days. The siRNA sequences are listed below:
siRNA Sequence
NTC UGGUUUACAUGUCGACUAA
UGGUUUACAUGUUGUGUGA
UGGUUUACAUGUUUUCUGA
UGGUUUACAUGUUUUCCUA
siEFL1 ACAUGAAGCAUGUCGCUAU
ACAUGAACGCAGUACGAAA
AAAGAGAGAAGGUCGGGUA
GCCAGUAGAUACCGAGAUU
siLSG1 GAAAUGACUUGCAGCGGAA (1)
AGAUAGUAGAUGCUCGAAA (2)
AGGGAUGGUUCACGAGACA (3)
GCCAAUAAGGAGAACGUCA (4)
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4.6 | Western blotting and antibodies
Cells were lysed in cell lysis buffer (Cell Signaling, 9803S) sup‐
plemented with EDTA‐free protease inhibitors for 10 min on ice. 
Protein content quantification and normalization were performed by 
Bradford assay. Lysates were separated by sodium dodecyl sulphate 
(SDS)–polyacrylamide gel electrophoresis (PAGE) and transferred to 
polyvinylidene difluoride (PVDF) membrane in a wet‐transfer man‐
ner. The membrane was incubated in blocking buffer (5% nonfat 
milk/Tris‐buffered saline (TBS)/0.1% Tween‐20) for 1 hr at room tem‐
perature (RT) for the blocking of nonspecific sites. Primary and HRP‐
linked secondary antibodies were diluted in blocking buffer. Primary 
antibody incubation was o/n, whereas secondary antibody lasted for 
1 hr at RT. The SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Scientific, 34079) was used for signal development, which 
was digitally detected in a Biorad detector (731BR00785) and ana‐
lysed using the software Image lab 4.1. Antibodies used were raised 
against: LSG1 (Proteintech 17750), EFL1 (24729), SBDS (Abcam 
ab128946), RPL28 (Proteintech 16649), BrdU (Pharmingen 558599), 
p53 (Santa Cruz sc‐126), p16 (Santa Cruz sc‐56330), p21 (Sigma 
p1484), pST/Q (Cell Signaling 2851), IL‐1α (R&D MAB200), IL‐1β 
(R&D MAB201), IL‐6 (R&D AF206NA), IL‐8 (R&D MAB208), Ki67 
(Invitrogen 180191Z), calnexin Alexa Fluor 647 conjugate (Abcam 
ab202572), SQLE (Bethyl Laboratories A304‐590A‐T) and HMGCS1 
(Proteintech 12544‐1‐AP).
4.7 | Immunofluorescence staining and High 
Content Microscopy
High content microscopy was performed as previously described 
(Hari & Acosta, 2017). Where included, cells were treated with 
50 mM BrdU (Sigma, 858811) for 16 hr prior to fixation. Briefly, 
cells were fixed with 10% formalin for 10 min, permeabilized with 
0.2% Triton/PBS for 10 min and then blocked with blocking solution 
(1% BSA/0.2% fish gelatin in PBS) for 1 hr. Primary antibody diluted 
in blocking solution was then added, and the cells were incubated 
for 1 hr at RT. Anti‐BrdU solution was supplemented with 0.5 U/
μl DNAse (Sigma D4527) and 1 mM MgCl2. Incubation with fluo‐
rescent secondary antibodies for 1 hr and 1 μg/ml DAPI for 30 min 
followed. The cells were visualized using confocal microscopy. 96‐
well plates were scanned using an ImageXpress Micro High Content 
Imaging System (Molecular Devices), acquiring multiple images. 
Automated analysis of these images was performed using the soft‐
ware MetaXpress 5.1.0.46 (Molecular Devices).
4.8 | Cytochemical staining for SA‐β‐galactosidase
Cell fixation was performed in 0.5% glutaraldehyde/PBS for 15 min 
at RT. After washes in 1 mM MgCl2/PBS, pH 6, the cells were incu‐
bated in staining solution [2 mg/ml 5‐bromo‐4‐chloro‐3‐indolyl‐β‐D‐
galactopyranoside (Sigma, B4252), 1.64 mg/ml K3Fe(CN)6, 2.1 mg/ml 
K4Fe(CN)6.3H2O in 1 mM MgCl2 1, pH 6] at 37°C, for 24 hr. The 
production of a blue precipitate within the cytoplasm, as observed 
under an inverted microscope, determined the lysosomal SA‐β‐gal 
activity (Dimri et al., 1995).
4.9 | O‐propargyl puromycin assay
For the OPP assay, the Click‐iT Plus OPP Alexa Fluor 488 kit (Thermo 
Fisher, C10456) was used, following the manufacturer's protocol. 
Briefly, transduced MRC5 cells were labelled with 20 μM OPP in 
dimethyl sulfoxide (DMSO) for 30 min. O‐propargyl puromycin in‐
tensity detection was performed by standard immunofluorescence 
procedures, followed by high content microscopy.
4.10 | Cell apoptosis assay
The cell apoptosis assay was carried out using the Annexin V and 
Dead Cell Assay Kit on the Muse (Merck Millipore) according to 
manufacturer's instructions.
4.11 | Quantitative real‐time PCR
RNA was extracted using the RNeasy Mini Kit (Qiagen, 74104) and 
reverse‐transcribed with the QScript enzyme (Quanta, 95048), ac‐
cording to the manufacturer's protocol. The cDNA obtained was 
used as a template for qPCR. Primers were used at 200 nM each in 
a total reaction volume of 20 μl. SYBR Select Master Mix (Applied 
Biosystems, 4472908) was used for the reaction, which was per‐
formed in a StepOne Real‐Time PCR system (Applied Biosciences), 
using the software StepOne v2.3. The primer oligos are listed below:
Actin: CATGTACGTTGCTATCCAGGC / CTCCTTAATGTCACGCACGAT
SerpinE1: CCTGGCCTCAGACTTCGGGGT / GGGGCCATGCCCTTG 
TCATCAAT
TGFB2: TGATCCTGCATCTGGTCACG / ATGGCATCAAGGTACCCACA
18S: GATGGTAGTCGCCGTGCC / GCCTGCTGCCTTCCTTGG
28S: AGAGGTAAACGGGTGGGGTC / GGGGTCGGGAGGAACGG
MSMO1: ATGCTTTGGTTGTGCAGTCA / TCACACAAAAGCACGAT 
TCC
DHCR7: GACAACTGGATCCCACTGCT / TCCGAGGGTTAAACTCGATG
MVD: GTGTCTACGGCGTGGAGAGT / ACGGTACTGCCTGTCAGCTT
HMGCS1: TCTAGCTCGGATGTTGCTGA / AACAGATGCAAGGGAACCAT
SQLE: GTCTCCGGAAAGCAGCTATG / AAAAGCCCATCTGCAACAAC
FDFT1: ATAACCAATGCACTGCACCA / CCTTTCCGAATCTTCACTGC
IL1A: AGTGCTGCTGAAGGAGATGCCTGA / CCCCTGCCAAGCACA 
CCCAGTA
IL1B: TGCACGCTCCGGGACTCACA / CATGGAGAACACCACTT 
GTTGCTCC
IL8: GAGTGGACCACACTGCGCCA / TCCACAACCCTCTGCACCCAGT
p21: CCTGTCACTGTCTTGTACCCT / GCGTTTGGAGTGGTAGAAATCT
p16: CGGTCGGAGGCCGATCCAG / GCGCCGTGGAGCAGCAG 
CAGCT
p53: CCGCAGTCAGATCCTAGCG / AATCATCCATTGCTTGGGACG
LSG1: ACTTTCAGACTCTCTATGTGG / AAACTAGTGATACAGGAG 
GAAC
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4.12 | Transcriptomic analysis
RNA was harvested from cells using an RNeasy/QIAshredder 
(Qiagen) protocol following the manufacturer's instructions. 
Reverse transcription of DNA was carried out using QScript enzyme 
(Quanta), and RNA was submitted to the Genome analysis core at the 
Wellcome Trust Clinical Research Facility (Western General Hospital) 
for AmpliSeq library preparation and IonTorrent sequencing. RNA 
samples were assessed for quality on the Agilent Bioanalyser with 
the RNA Nano chip, providing an RNA Integrity Number (RIN). 
Samples were quantified using the Qubit® 2.0 fluorometer and the 
Qubit® RNA Broad Range assay. 10 ng of RNA was reverse‐tran‐
scribed to make cDNA, and then, target genes were amplified for 
12 cycles of PCR using the Ion AmpliSeq™ Human Gene Expression 
Core Panel, which contains a pool of 20,802 amplicons (41,604 prim‐
ers) of approximately 150 bases in length. Ion Torrent sequencing 
adapters and barcodes were ligated to the amplicons, and adapter‐
ligated libraries were purified using AMPure XP beads. Libraries 
were quantified by qPCR and diluted to 100 pM. Templates were 
prepared using the Ion PI Hi‐Q OT2 200 Kit and sequenced using 
the Ion PI Hi‐Q Sequencing 200 Kit. The Ion Proton platform was 
used to process the sequencing. Analysis of the data was performed 
using the Babelomics‐5 application (http://babel omics.bioin fo.cipf.
es). The sample replicates were normalized using trimmed mean of M 
values (TMM) method and subjected to the Benjamini and Hochberg 
false discovery rate multiple test correction method to adjust the 
p‐value. AmpliSeq transcriptomic data have been deposited at the 
Gene Expression Omnibus under the accession number GSE128055. 
Hierarchical clustering analysis was performed using Cluster 3 soft‐
ware (Stanford University), and visualization was performed using 
TreeView 3.0 software (Princeton University). Preranked gene lists 
by fold change were subjected to gene set enrichment analysis 
(GSEA) using the GSEA 3.0 software from the Broad Institute (www.
gseamsigdb.org). Preranked gene expression transcriptomes were 
interrogated against gene set data bases at the Broad Institute re‐
pository. The enrichment statistics used was adjusted to weighted. 
The maximum and minimum size of the sets was adjusted to 500 to 
10, respectively. The number of permutations was adjusted to 1,000. 
The normalization mode was meandiv. The Gene Ontology analysis 
of gene lists was performed using the DAVID functional annotation 
tool (https ://david.ncifc rf.gov/tools.jsp).
4.13 | Polysome profiles
Cells were lysed in detergent lysis buffer A (10 mM Tris‐HCl at pH 
7.4, 10 mM NaCl, 1.5 mM MgCl2, 0.5% [v/v] Triton X‐100, 0.5% 
[w/v] deoxycholate, 1% [v/v] Tween‐20, 100 μg/ml cycloheximide) 
with complete EDTA‐free protease inhibitors (Roche) and 0.5 U/ml 
RNase inhibitor (Promega) and incubated for 10 min on ice. Lysates 
were cleared in a microfuge. Equal amounts (typically 10–20 A254 
U) were applied to a 10%–50% (w/v) sucrose gradient in 11 ml of 
buffer B (10 mM Tris‐HCl at pH 7.4, 75 mM KCl, 1.5 mM MgCl2) 
and centrifuged (Beckman SW41 rotor) at 207,570 g for 80 min at 
4°C. Samples were unloaded using a Brandel gradient fractionator, 
the polysome profiles were detected using a UV monitor (Gilson) 
at A254, and fractions were collected. For analysis of polysome‐
associated mRNAs, polysomal fractions were pooled and RNA was 
purified using the RNeasy Mini Kit (Qiagen). RNA was reverse‐
transcribed with QScript enzyme (Quanta) according to the manu‐
facturer's protocol, and the cDNA was used as a template for PCR. 
Primer oligos used were as follows:
p16: CGGTCGGAGGCCGATCCAG / GCGCCGTGGAGCAGCAGC 
AGCT
p21: CCTGTCACTGTCTTGTACCCT / GCGTTTGGAGTGGTAGAA 
ATCT
IL1α: AGTGCTGCTGAAGGAGATGCCTGA / CCCCTGCCAAGCAC 
ACCCAGTA
β‐actin: CATGTACGTTGCTATCCAGGC / CTCCTTAATGTCACGCA 
CGAT
4.14 | Crystal violet assay
Cells were seeded at low density and cultured for 15 days. Fixation was 
performed in 1% glutaraldehyde/PBS for 1 hr, at RT. After two H2O 
washes, the plates were left to dry for 1 day. Staining was performed 
using 0.15% crystal violet/H2O for 2 hr at room temperature, followed 
by washes with tap water. The dishes were dried, and photographs 
were taken using a document scanner. For relative quantitation pur‐
poses, the crystal violet was extracted in 1 M acetic acid/H2O during 
an overnight incubation and the absorbance at 595 nm was measured.
4.15 | Statistics
Experiments were performed with biological triplicates and re‐
peated multiple times. Error bars are standard deviations. p‐Values 
are derived from two‐tailed t tests or one‐way analysis of variance 
(ANOVA) with the appropriate post hoc correction for multiple com‐
parisons as indicated in the figure legends. Significance symbols are 
as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
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